Chinese Journal of Antituberculosis ›› 2021, Vol. 43 ›› Issue (12): 1248-1259.doi: 10.3969/j.issn.1000-6621.2021.12.005
• Original Articles • Previous Articles Next Articles
ZHANG Hui*, CHENG Jun, YU Yan-ling, SHEN Xin, LU Wei, WANG Xiao-meng, YAO Yu-xia, HOU Shuang-yi, LI Jian-wei, ZHAO Jin-ming, XIA Lan, XU Lin, ZHANG Can-you, ZHAO Fei, XIA Yin-yin, CHEN Hui, WANG Li-xia()
Received:
2021-09-10
Online:
2021-12-10
Published:
2021-12-01
Contact:
WANG Li-xia
E-mail:wanglx@chinacdc.cn
ZHANG Hui, CHENG Jun, YU Yan-ling, SHEN Xin, LU Wei, WANG Xiao-meng, YAO Yu-xia, HOU Shuang-yi, LI Jian-wei, ZHAO Jin-ming, XIA Lan, XU Lin, ZHANG Can-you, ZHAO Fei, XIA Yin-yin, CHEN Hui, WANG Li-xia. Evaluation of the effectiveness of community-based pulmonary tuberculosis active case-finding among key populations: a multicenter prospective cohort study[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1248-1259. doi: 10.3969/j.issn.1000-6621.2021.12.005
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2021.12.005
特征 | 2013年 (42684名) | 2014年 (41732名) | 2015年 (42441名) |
---|---|---|---|
性别 | |||
男性 | 19930(46.7) | 19582(46.9) | 20020(47.2) |
女性 | 22754(53.3) | 22150(53.1) | 22421(52.8) |
年龄组(岁) | |||
0~14 | 108(0.3) | 115(0.3) | 169(0.4) |
15~24 | 124(0.3) | 103(0.3) | 122(0.3) |
25~34 | 207(0.5) | 213(0.5) | 249(0.6) |
35~44 | 524(1.2) | 463(1.1) | 490(1.2) |
45~54 | 1326(3.1) | 1312(3.1) | 1337(3.1) |
55~64 | 2406(5.6) | 2313(5.5) | 2331(5.5) |
≥65 | 37989(89.0) | 37213(89.2) | 37743(88.9) |
职业 | |||
儿童、学生 | 242(0.6) | 277(0.7) | 3519(0.8) |
教师 | 208(0.5) | 205(0.5) | 244(0.6) |
服务人员 | 251(0.6) | 283(0.7) | 298(0.7) |
医务人员 | 88(0.2) | 95(0.2) | 105(0.3) |
工人 | 1024(2.4) | 1091(2.6) | 1148(2.7) |
农、牧、渔(船)民 | 23368(54.7) | 24572(58.9) | 25716(60.6) |
干部职员 | 337(0.8) | 358(0.9) | 370(0.9) |
离退人员 | 10146(23.8) | 9911(23.7) | 9311(21.9) |
家务及待业 | 3507(8.2) | 3441(8.2) | 3383(8.0) |
其他 | 1009(2.4) | 987(2.4) | 999(2.3) |
不详 | 2504(5.8) | 512(1.2) | 516(1.2) |
文化程度 | |||
文盲或半文盲 | 14306(33.5) | 14267(34.2) | 13922(32.8) |
小学 | 15006(35.2) | 15340(36.8) | 15765(37.2) |
初中 | 6607(15.5) | 6838(16.4) | 7132(16.8) |
高中或中专 | 3421(8.0) | 3359(8.0) | 3565(8.4) |
大专及以上 | 1501(3.5) | 1535(3.7) | 1620(3.8) |
不详 | 1843(4.3) | 393(0.9) | 437(1.0) |
城乡 | |||
城镇 | 15148(35.5) | 15191(36.4) | 14648(34.5) |
乡村 | 27536(64.5) | 26541(63.6) | 27793(65.5) |
地区 | |||
东部 | 16185(37.9) | 15526(37.2) | 16451(38.7) |
中部 | 9479(22.2) | 9347(22.4) | 9366(22.1) |
西部 | 17020(39.9) | 16859(40.4) | 16624(39.2) |
吸烟史 | |||
从不吸烟 | 34051(79.8) | 32803(78.6) | 32445(76.4) |
过去吸烟 | 2024(4.7) | 1920(4.6) | 1889(4.5) |
现在吸烟 | 6490(15.2) | 6449(15.5) | 6823(16.1) |
缺失 | 119(0.3) | 560(1.3) | 1284(3.0) |
饮酒史 | |||
从不饮酒 | 34282(80.3) | 32854(78.7) | 32540(76.7) |
曾经饮酒 | 1556(3.7) | 1472(3.5) | 1467(3.5) |
现在饮酒 | 6671(15.6) | 6786(16.3) | 7095(16.7) |
缺失 | 175(0.4) | 620(1.5) | 1339(3.1) |
体质量指数 | |||
<18.5 | 4561(10.7) | 4620(11.1) | 5153(12.1) |
18.5~23.9 | 25722(60.3) | 24962(59.8) | 24832(58.5) |
≥24.0 | 12401(29.0) | 12150(29.1) | 12456(29.4) |
重点人群 | 人数 (名) | 核心信息总 知晓数(条) | 总知晓 率(%) |
---|---|---|---|
2013年 | |||
全部重点人群 | 42684 | 73066 | 34.2 |
65岁及以上老年人 | 37989 | 61723 | 32.5 |
已知糖尿病患者 | 5642 | 12340 | 43.7 |
既往结核病患者 | 1684 | 4633 | 55.0 |
肺结核患者密切接触者 | 593 | 992 | 33.5 |
HIV/AIDS者 | 83 | 199 | 48.0 |
2014年 | |||
全部重点人群 | 41732 | 119416 | 57.2 |
65岁及以上老年人 | 37219 | 104072 | 55.9 |
已知糖尿病患者 | 5855 | 19387 | 66.2 |
既往结核病患者 | 1620 | 5575 | 68.8 |
肺结核患者密切接触者 | 756 | 2278 | 60.3 |
HIV/AIDS者 | 82 | 307 | 74.9 |
2015年 | |||
全部重点人群 | 42441 | 142629 | 67.2 |
65岁及以上老年人 | 37771 | 124315 | 65.8 |
已知糖尿病患者 | 6002 | 22580 | 75.2 |
既往结核病患者 | 1488 | 5885 | 79.1 |
肺结核患者密切接触者 | 1126 | 3972 | 70.6 |
HIV/AIDS者 | 76 | 323 | 85.0 |
重点人群 | 筛查数 (名) | 任一症状 [例(发生率,%)] | 规划可疑症状 [例(发生率,%)] | 研究可疑症状 [例(发生率,%)] | ||||
---|---|---|---|---|---|---|---|---|
2013年 | ||||||||
全部重点人群 | 42684 | 1831(4.3) | 932(2.2) | 1025(2.4) | ||||
65岁及以上老年人 | 37989 | 1509(4.0) | 731(1.9) | 798(2.1) | ||||
已知糖尿病患者 | 5642 | 268(4.8) | 152(2.7) | 167(3.0) | ||||
既往结核病患者 | 1684 | 281(16.7) | 178(10.6) | 207(12.3) | ||||
肺结核患者密切接触者 | 593 | 23(3.9) | 14(2.4) | 14(2.4) | ||||
HIV/AIDS者 | 83 | 3(3.6) | 0(0.0) | 0(0.0) | ||||
2014年 | ||||||||
全部重点人群 | 41732 | 491(1.2) | 38(0.1) | 40(0.1) | ||||
65岁及以上老年人 | 37219 | 423(1.1) | 30(0.1) | 32(0.1) | ||||
已知糖尿病患者 | 5855 | 99(1.7) | 14(0.2) | 14(0.2) | ||||
既往结核病患者 | 1620 | 53(3.3) | 7(0.4) | 7(0.4) | ||||
肺结核患者密切接触者 | 756 | 3(0.4) | 0(0.0) | 0(0.0) | ||||
HIV/AIDS者 | 82 | 0(0.0) | 0(0.0) | 0(0.0) | ||||
重点人群 | 筛查数 (名) | 任一症状 [例(发生率,%)] | 规划可疑症状 [例(发生率,%)] | 研究可疑症状 [例(发生率,%)] | ||||
2015年 | ||||||||
全部重点人群 | 42441 | 349(0.8) | 237(0.6) | 258(0.6) | ||||
65岁及以上老年人 | 37771 | 307(0.8) | 204(0.5) | 221(0.6) | ||||
已知糖尿病患者 | 6002 | 62(1.0) | 36(0.6) | 43(0.7) | ||||
既往结核病患者 | 1488 | 34(2.3) | 27(1.8) | 28(1.9) | ||||
肺结核患者密切接触者 | 1126 | 7(0.6) | 7(0.6) | 7(0.6) | ||||
HIV/AIDS者 | 76 | 0(0.0) | 0(0.0) | 0(0.0) |
重点人群 | 筛查数 (名) | 结核病或疑似 结核病病灶 [例(构成比, %)] | 其他病灶 [例(构成 比,%)] |
---|---|---|---|
2013年 | |||
全部重点人群 | 37538 | 1289(3.3) | 1736(4.6) |
65岁及以上老年人 | 33717 | 913(2.7) | 1652(4.9) |
已知糖尿病患者 | 5018 | 87(1.7) | 103(2.1) |
既往结核病患者 | 1505 | 462(30.7) | 116(7.7) |
肺结核患者密切接触者 | 344 | 18(5.2) | 6(1.7) |
HIV/AIDS者 | 59 | 5(8.5) | 1(1.7) |
2014年 | |||
全部重点人群 | 37070 | 1109(3.0) | 1205(3.3) |
65岁及以上老年人 | 33686 | 872(2.6) | 1153(3.4) |
已知糖尿病患者 | 5037 | 100(2.0) | 128(2.5) |
既往结核病患者 | 1305 | 400(30.7) | 63(4.8) |
肺结核患者密切接触者 | 489 | 9(1.8) | 8(1.6) |
HIV/AIDS者 | 62 | 4(6.5) | 0(0.0) |
2015年 | |||
全部重点人群 | 36483 | 1047(2.9) | 690(1.9) |
65岁及以上老年人 | 33268 | 842(2.5) | 655(2.0) |
已知糖尿病患者 | 5121 | 78(1.5) | 63(1.2) |
既往结核病患者 | 1185 | 338(28.5) | 60(5.1) |
肺结核患者密切接触者 | 626 | 16(2.6) | 4(0.6) |
HIV/AIDS者 | 68 | 2(2.9) | 0(0.0) |
重点人群 | 菌阳肺结核 | 活动性肺结核 | |||||
---|---|---|---|---|---|---|---|
全部患者(例) | 主动发现(例) | 贡献率(%) | 全部患者(例) | 主动发现(例) | 贡献率(%) | ||
2013年 | |||||||
全部重点人群 | 84 | 77 | 91.7 | 255 | 244 | 95.7 | |
65岁及以上老年人 | 56 | 52 | 92.9 | 174 | 167 | 96.0 | |
已知糖尿病患者 | 11 | 11 | 100.0 | 24 | 23 | 95.8 | |
既往结核病患者 | 31 | 28 | 90.3 | 90 | 84 | 93.3 | |
肺结核患者密切接触者 | 2 | 2 | 2/2 | 9 | 9 | 9/9 | |
HIV/AIDS者 | 1 | 0 | 0.0 | 3 | 2 | 2/3 | |
2014年 | |||||||
全部重点人群 | 58 | 44 | 75.9 | 247 | 200 | 81.0 | |
65岁及以上老年人 | 42 | 35 | 83.3 | 186 | 162 | 87.1 | |
已知糖尿病患者 | 2 | 1 | 1/2 | 18 | 17 | 94.4 | |
既往结核病患者 | 23 | 18 | 78.3 | 90 | 69 | 76.7 | |
肺结核患者密切接触者 | 1 | 0 | 0.0 | 2 | 0 | 0.0 | |
HIV/AIDS者 | 0 | 0 | 0.0 | 1 | 1 | 1/1 | |
2015年 | |||||||
全部重点人群 | 53 | 36 | 67.9 | 153 | 112 | 73.2 | |
65岁及以上老年人 | 39 | 29 | 74.4 | 122 | 96 | 78.7 | |
已知糖尿病患者 | 5 | 1 | 1/5 | 11 | 6 | 54.6 | |
既往结核病患者 | 7 | 5 | 5/7 | 20 | 12 | 60.0 | |
肺结核患者密切接触者 | 1 | 1 | 1/1 | 6 | 5 | 5/6 | |
HIV/AIDS者 | 1 | 0 | 0.0 | 1 | 0 | 0.0 | |
合计 | |||||||
全部重点人群 | 195 | 157 | 80.5 | 655 | 556 | 84.9 | |
65岁及以上老年人 | 137 | 116 | 84.7 | 482 | 425 | 88.2 | |
已知糖尿病患者 | 18 | 13 | 72.2 | 53 | 46 | 86.8 | |
既往结核病患者 | 61 | 51 | 83.6 | 200 | 165 | 82.5 | |
肺结核患者密切接触者 | 4 | 3 | 3/4 | 17 | 14 | 82.4 | |
HIV/AIDS者 | 2 | 0 | 0.0 | 5 | 3 | 3/5 |
影响因素 | 患者数 (例) | 主动发现 | χ2值 | P值 | OR(95%CI)值 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
患者数(例) | 贡献率(%) | ||||||||||
性别 | 0.025 | 0.875 | |||||||||
男性 | 474 | 403 | 85.0 | 1.04(0.65~1.67) | |||||||
女性 | 181 | 153 | 84.5 | - | |||||||
年龄组(岁) | 28.574 | <0.01 | |||||||||
15~24 | 12 | 7 | 58.3 | - | |||||||
25~34 | 15 | 8 | 53.3 | 0.82(0.18~3.78) | |||||||
35~44 | 22 | 17 | 77.3 | 2.43(0.53~11.11) | |||||||
45~54 | 53 | 39 | 73.6 | 1.99(0.54~7.30) | |||||||
55~64 | 71 | 60 | 84.5 | 3.90(1.05~14.52) | |||||||
≥65 | 482 | 425 | 88.2 | 5.33(1.64~17.34) | |||||||
文化程度 | 25.008 | <0.01 | |||||||||
文盲或半文盲 | 216 | 191 | 88.4 | 6.37(1.81~22.40) | |||||||
小学 | 267 | 236 | 88.4 | 6.34(1.83~22.02) | |||||||
初中 | 125 | 92 | 73.6 | 2.32(0.66~8.12) | |||||||
高中或中专 | 36 | 31 | 86.1 | 5.17(1.13~23.55) | |||||||
大专及以上 | 11 | 6 | 54.5 | - | |||||||
城乡 | 3.674 | 0.055 | |||||||||
城镇 | 132 | 105 | 79.5 | - | |||||||
乡村 | 523 | 451 | 86.2 | 1.61(0.99~2.63) | |||||||
地区 | 6.974 | 0.031 | |||||||||
东部 | 146 | 118 | 80.8 | - | |||||||
中部 | 171 | 139 | 81.3 | 1.03(0.59~1.81) | |||||||
西部 | 338 | 299 | 88.5 | 1.82(1.07~3.09) | |||||||
吸烟史 | 1.370 | 0.242 | |||||||||
有 | 198 | 173 | 87.4 | - | |||||||
无 | 457 | 383 | 83.8 | 0.75(0.46~1.22) | |||||||
饮酒史 | 0.324 | 0.569 | |||||||||
有 | 183 | 153 | 83.6 | - | |||||||
无 | 472 | 403 | 85.4 | 1.15(0.72~1.83) | |||||||
体质量指数 | 0.465 | 0.793 | |||||||||
<18.5 | 107 | 93 | 86.9 | 1.29(0.59~2.85) | |||||||
18.5~23.9 | 456 | 386 | 84.6 | 1.07(0.58~1.97) | |||||||
≥24 | 92 | 77 | 83.7 | - | |||||||
症状和就诊知识 | 2.062 | 0.357 | |||||||||
全知晓 | 269 | 234 | 87.0 | - | |||||||
知晓其一 | 119 | 97 | 81.5 | 0.66(0.37~1.18) | |||||||
全不知晓 | 267 | 225 | 84.3 | 0.80(0.49~1.30) | |||||||
影响因素 | 患者数 (例) | 主动发现 | χ2值 | P值 | OR(95%CI)值 | ||||||
患者数(例) | 贡献率(%) | ||||||||||
肺结核规划症状 | 5.219 | 0.022 | |||||||||
有 | 69 | 65 | 94.2 | - | |||||||
无 | 586 | 491 | 83.8 | 0.32(0.11~0.89) | |||||||
糖尿病 | 0.163 | 0.686 | |||||||||
有 | 53 | 46 | 86.8 | - | |||||||
无 | 602 | 510 | 84.7 | 0.84(0.37~1.93) | |||||||
既往结核病 | 1.277 | 0.259 | |||||||||
是 | 200 | 165 | 82.5 | - | |||||||
否 | 455 | 391 | 85.9 | 1.30(0.83~2.03) | |||||||
肺结核患者密切接触者 | - | 0.732a | |||||||||
是 | 17 | 14 | 82.4 | - | |||||||
否 | 638 | 542 | 85.0 | 1.21(0.34~4.29) | |||||||
HIV/AIDS者 | - | 0.166a | |||||||||
是 | 5 | 3 | 3/5 | - | |||||||
否 | 650 | 553 | 85.1 | 3.80(0.63~23.04) |
变量 | 赋值 | 变量 | 赋值 |
---|---|---|---|
是否主动发现 | 主动发现=1;非主动发现=0 | 饮酒史 | 有=1;无=0; |
性别 | 男性=1;女性=2 | ||
体质量指数 | <18.5=1;18.5~23.9=2;≥24=3 | ||
年龄组 | 15~24岁=1;25~34岁=2;35~44岁=3;45~54岁=4;55~64岁=5;≥65岁=6 | ||
症状和就诊知识 | 全知晓=1;知晓其一=2;全不知晓=3 | ||
肺结核规划症状 | 有=1;无=0 | ||
文化程度 | 文盲或半文盲=1;小学=2;初中=3;高中或中专=4;大专及以上=5 | ||
糖尿病 | 有=1;无=0 | ||
既往结核病 | 是=1;否=0; | ||
城乡 | 城镇=1;乡村=2 | ||
肺结核患者密切接触者 | 是=1;否=0 | ||
地区 | 东部=1;中部=2;西部=3 | ||
HIV/AIDS者 | 是=1;否=0 | ||
吸烟史 | 有=1;无=0; |
影响因素 | β值 | s | Wald χ2值 | P值 | 调整OR(95%CI)值 | |||||
---|---|---|---|---|---|---|---|---|---|---|
性别(以“女性”为参照) | ||||||||||
男性 | 1.056 | 0.860 | 0.526 | 0.468 | 1.20(0.73~1.99) | |||||
年龄组(以“15~24岁”为参照) | ||||||||||
25~34岁 | -0.225 | 0.895 | 0.063 | 0.802 | 0.80(0.14~4.62) | |||||
35~44岁 | 1.472 | 0.873 | 2.840 | 0.092 | 4.36(0.79~24.14) | |||||
45~54岁 | 1.104 | 0.710 | 2.104 | 0.147 | 3.02(0.68~13.40) | |||||
55~64岁 | 1.972 | 0.769 | 6.580 | 0.010 | 7.18(1.59~32.39) | |||||
≥65岁 | 2.604 | 0.718 | 13.167 | 0.000 | 13.52(3.31~55.16) | |||||
影响因素 | β值 | s | Wald χ2值 | P值 | 调整OR(95%CI)值 | |||||
地区(以“东部”为参照) | ||||||||||
中部 | 0.345 | 0.309 | 1.245 | 0.265 | 1.41(0.77~2.59) | |||||
西部 | 0.891 | 0.289 | 9.530 | 0.002 | 2.44(1.38~4.29) | |||||
症状和就诊知识(以“全知晓”为参照) | ||||||||||
知晓其一 | -0.829 | 0.326 | 6.462 | 0.011 | 0.44(0.23~0.83) | |||||
全不知晓 | -0.540 | 0.274 | 3.885 | 0.049 | 0.58(0.34~1.00) | |||||
肺结核规划症状(以“有”为参照) | ||||||||||
无肺结核规划症状 | -1.884 | 0.589 | 10.223 | 0.001 | 0.15(0.05~0.48) |
[1] | World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization, 2014. |
[2] | World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. Geneva: World Health Organization, 2013. |
[3] | World Health Organization. WHO consolidated guidelines on tuberculosis. Module 2: screening-systematic screening for tuberculosis disease. Geneva: World Health Organization, 2021. |
[4] |
Ho J, Fox GJ, Marais BJ. Passive case-finding for tuberculosis is not enough. Int J Mycobacteriol, 2016, 5(4):374-378. doi: 10.1016/j.ijmyco.2016.09.023.
doi: 10.1016/j.ijmyco.2016.09.023 URL |
[5] | World Health Organization. The End TB Strategy. Geneva: World Health Organization, 2015. |
[6] | 卫生部疾病预防控制局, 卫生部医政司, 中国疾病预防控制中心. 中国结核病防治规划实施工作指南 (2008年版). 北京: 中国协和医科大学出版社, 2009. |
[7] | 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012, 34(8):485-508. |
[8] |
Marks GB, Nguyen NV, Nguyen PTB, et al. Community-wide screening for tuberculosis in a high-prevalence setting. N Engl J Med, 2019, 381(14):1347-1357. doi: 10.1056/NEJMoa1902129.
doi: 10.1056/NEJMoa1902129 URL |
[9] |
Kim H, Kim HJ, Oh KH, et al. A Pilot Project of Systematic Tuberculosis Screening in the Elderly in a South Korean Pro-vince. Tuberc Respir Dis (Seoul), 2019, 82(3):194-200. doi: 10.4046/trd.2018.0063.
doi: 10.4046/trd.2018.0063 URL |
[10] |
Camelique O, Scholtissen S, Dousset JP, et al. Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia. Int J Tuberc Lung Dis, 2019, 23(10):1107-1114. doi: 10.5588/ijtld.18.0611.
doi: 10.5588/ijtld.18.0611 pmid: 31627776 |
[11] | World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020. |
[12] |
Cheng J, Wang L, Zhang H, et al. Diagnostic value of symptom screening for pulmonary tuberculosis in China. PLoS One, 2015, 10(5):e0127725. doi: 10.1371/journal.pone.0127725.
doi: 10.1371/journal.pone.0127725 URL |
[13] |
Chen JO, Qiu YB, Rueda ZV, et al. Role of community-based active case-finding in screening tuberculosis in Yunnan pro-vince of China. Infect Dis Poverty, 2019, 8(1):92. doi: 10.1186/s40249-019-0602-0.
doi: 10.1186/s40249-019-0602-0 URL |
[14] | World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization, 2021. |
[15] | World Health Organization. A systematic review of the sensitivity and specificity of symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative persons and persons with unknown HIV status. Geneva: World Health Organization, 2013. |
[16] | World Health Organization. Chest radiography in tuberculosis detection: summary of current who recommendations and guidance on programmatic approaches. Geneva: World Health Organization, 2016 |
[17] |
Shewade HD, Gupta V, Ghule VH, et al. Impact of advocacy, communication, social mobilization and active case-finding on TB notification in Jharkhand, India. J Epidemiol Glob Health, 2019, 9(4):233-242. doi: 10.2991/jegh.k.190812.002.
doi: 10.2991/jegh.k.190812.002 pmid: 31854164 |
[18] |
Aye S, Majumdar SS, Oo MM, et al. Evaluation of a tuberculosis active case-finding project in peri-urban areas, Myanmar: 2014-2016. Int J Infect Dis, 2018, 70:93-100. doi: 10.1016/j.ijid.2018.02.012.
doi: 10.1016/j.ijid.2018.02.012 URL |
[1] | YANG Ting-ting, GAO Qian. The tuberculosis drug-resistance and transmission surveillance network based on whole genome sequencing data [J]. Chinese Journal of Antituberculosis, 2021, 43(7): 645-648. |
[2] | BAI Hua, GUO Jing-wei, HU Pei-lei, YI Song-lin, WEN Jia, LIU Feng-ping, TAN Yun-hong, BAI Li-qiong. Analysis of drug resistance surveillance results of Mycobacterium tuberculosis in Hu’nan Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 364-369. |
[3] | CHENG Jun, ZHANG Can-you, CHEN Hui, ZHANG Hui, ZHAO Yan-lin. Strengthen tuberculosis control strategy in key populations according to local conditions [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 217-221. |
[4] | SU Wei, LI Ren-zhong, RUAN Yun-zhou, JIANG Jia-wen, WANG Meng, XIE Tian, WANG Zhong-sheng, XU Wan-guang, FANG Guan-chen, ZENG Yan, TANG Wen-fang. Effect of sputum sample quality intervention on the positive detection rate of etiology in newly diagnosed pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1269-1274. |
[5] | XIA Jing, CHEN Lei, QIN Jia, ZHU Xi, LI Jun. Analysis of pulmonary tuberculosis surveillance results of entry-exit population at Shanghai port from 2014 to 2020 [J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1297-1301. |
[6] | WU Hui-zhong, ZHOU Fang-jing, LIAO Qing-hua, CHEN Liang, LAI Xiao-yu, YU Mei-ling, WEN Wen-pei, ZHOU Lin. Analysis of the implementation effect of active tuberculosis screening strategy in permanent residents aged 5 and older in Lianjiangkou Town, Guangdong in 2019 [J]. Chinese Journal of Antituberculosis, 2021, 43(10): 1032-1038. |
[7] | ZHU Li-mei, CHEN Can-can, CHEN Wei, HU Xiao-guang, ZHANG Ya-nan, MA Jun-yang. To formulate prevention and control strategy for latent tuberculosis infection population in China [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 794-798. |
[8] | WANG Ni, HUANG Fei, LI Tao, LI You, SUN Miao-miao, ZHANG Hui, ZHAO Yan-lin, DU Xin. Establishment and validation of the standard basic dataset for tuberculosis surveillance [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 667-670. |
[9] | DU Xin, LI Tao, LI You, SUN Miao-miao, WANG Ni, ZHANG Hui, ZHAO Yan-lin, HUANG Fei. Pilot exploration of a New TB Surveillance System based on the National Health Security Project Construction Plan [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 662-666. |
[10] | LI Tao, DU Xin, CHEN Wei, HUANG Fei, ZHAO Yan-lin, ZHANG Hui. Review and prospect of tuberculosis management information surveillance and monitoring in China [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 657-661. |
[11] | CHENG Jun, LIU Jian-jun. Current status and progress of surveillance and automated-alert for tuberculosis in school [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 436-441. |
[12] | LI Jin,GUO Xiao-qin,LI Yong,ZOU Jin-yan,LU Li-ping. Analysis on the effect of active screening of tuberculosis among local people aged 65 or older in Songjiang District of Shanghai in 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 353-359. |
[13] | LU Peng,CHENG Jun,LU Xi-wei,LIU Er-yong,ZHOU Lin,LU Wei. Scientific preventive treatment to accelerate the process of tuberculosis control [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 316-321. |
[14] | DU Ying, ZHANG Bin, WANG Da-kuan, ZHANG Hao-ran, XIN He-nan, JIN Qi, GAO Lei. Epidemiology and preventive intervention of inactive tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1232-1236. |
[15] | Hong-xia FANG,Guang-rong ZHANG,Yu-bao QIN,Zhi-min XIE,Keng LAI,Cheng-zhang HUANG,Yan WANG,Wen-long HE,Kai-qiao ZHENG,Zhi-kai XIAO,Chang-wei LIU,Jian-ping LIANG,Zhi-cong CHEN. Prediction models for latent tuberculosis infection among contacts of tuberculosis patients in an institutionalized population [J]. Chinese Journal of Antituberculosis, 2019, 41(9): 936-945. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||